| Value | ₹417.0 Cr |
|---|
BSE filing, NSE: KOLTEPATIL. Summary written from the filing by ALFA Finder's alert engine.
Kolte-Patil Developers Ltd: key numbers
- Share price
- ₹443.60
- Market cap
- ₹3,934 Cr
- Revenue (annual)
- ₹735.0 Cr
- Net profit (annual)
- ₹-38.67 Cr
- P/E (TTM)
- 31.6×Sector 34.4×
- Promoter holding
- 73.81%+0.00% QoQ
- FII holding
- 11.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kolte-Patil Developers Ltd
All →Kolte-Patil Developers Other Announcement
Kolte-Patil Developers filed CARE Ratings' monitoring report on preferential issue proceeds for the quarter ended 30 September 2026. The report records no deviation from the offer objects.
Kolte-Patil Developers Board Meeting Date
Kolte-Patil Developers intimated a board meeting on November 3, 2026 to consider unaudited standalone and consolidated results for Q2 and half-year ended September 30, 2026. The notice is advance intimation with agenda proposed only.
Kolte-Patil Developers Price Movement Clarification
Kolte-Patil responded to an NSE surveillance query on a volume spurt, stating no material event or undisclosed information. The company is unaware of any development behind the trading increase.
Kolte-Patil Developers Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance disclosure.
Kolte-Patil Developers Business Update
Kolte-Patil Developers reported record quarterly sales of Rs. 1,019 crore for Q2 FY27 and signed six new redevelopment projects in Mumbai worth Rs. 6,000 crore GDV.
- Value
- ₹6,000 Cr
Kolte-Patil Developers Credit Rating
CARE Ratings has reaffirmed the 'CARE AA-; Stable' rating for Kolte-Patil Developers Limited's Non-Convertible Debentures. The rating covers an instrument amount of Rs. 250 Crore.
- Value
- ₹250.0 Cr
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.